JET-AVERT MOTION SICKNESS AID- meclizine hydrochloride tablet 
Bell Pharmaceuticals, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Jet-Avert Motion Sickness Aid

Drug Facts

Active ingredient (in each tablet)

Meclizine HCL 25mg

Purpose

Antiemetic

Uses

Warnings

Do not use

  • for children under 12 years of age unless directed by a doctor

Ask a doctor  before use if you have

  • a breathing problem such as emphysema or chronic bronchitis
  • glaucome 
  • difficulty in urination due to enlargement prostate glad

Ask a doctor or pharmacist before useif you are taking

  • Sedatives • tranquilizers

When using this product

• drowsiness may occur • alcohol, sedatives, and tranquilizers may increase drowsiness • avoid alcoholic drinks • be careful when driving or operating machinery

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

 adults and children 12 years and over take 1 to 2 tablets once daily, or as directed by a doctor
 children under 12 years do not ues unless directed by doctor

Other information

Inactive ingredients

calcium stearate, FD&C red#40 aluminum lake, lactose, microcrystalline cellulose, silicon dioxide, sodium starch glycolate

Questions or comments?

1-800-328-5890 Weekdays 8:30-5:00 CST

Package Labeling:

Label

JET-AVERT MOTION SICKNESS AID 
meclizine hydrochloride tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:15579-837
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE25 mg
Inactive Ingredients
Ingredient NameStrength
CALCIUM STEARATE (UNII: 776XM7047L)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
LACTOSE (UNII: J2B2A4N98G)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
Product Characteristics
ColorredScoreno score
ShapeROUNDSize4mm
FlavorImprint Code 25
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:15579-837-233 in 1 BOX10/07/2017
18 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart33610/07/2017
Labeler - Bell Pharmaceuticals, Inc. (140653770)

Revised: 10/2017
Document Id: 5b1ce58c-5082-26d3-e053-2991aa0a7e6a
Set id: 1fe1f806-cbf3-4308-8d70-201756e96cd1
Version: 1
Effective Time: 20171009
 
Bell Pharmaceuticals, Inc.